Myeloma 2017 day 2 highlights: MRD, targeted therapies and imaging advances
Gareth Morgan et al.
Updates from the CLL14 and CLL2-GiVe trials on CLL
Breaking news from the ALCYONE study of VMP plus daratumumab for NDMM
Maria Victoria Mateos
Ibrutinib combination therapy in CLL: overview of the data so far
Paradigm-changing CAR T-cell therapy for multiple myeloma